<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240108060648N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-02-12</date_registration>
      <primary_sponsor>The university of Tabriz</primary_sponsor>
      <public_title>effect of circuit training in side effects of aging</public_title>
      <acronym></acronym>
      <scientific_title>The effect of 8 weeks of circular training on serum levels of Brain-Derived Neurotrophic Factor and Nerve Growth Factor in elderly women</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-03-04</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/74903</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Other design features: The participants will be divided into two groups: a control group and a training group. The effect of the independent variable will be compared between the two groups, one with intervention and one without, Randomization description: The sealed envelope method will be used. In this way, random numbers will be placed inside sealed envelopes. The patient's number will be written on each envelope, and the patient's names will be listed in order. Finally, envelopes will be opened and patients with an even number will be assigned to the training group, while those with an odd number will be assigned to the control group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>aging.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: They will engage in circuit training 2 or 3 times a week (2 times initially and up to 3 times later) for eight weeks. Then, they will do stretching exercises for the major muscle groups and rotational movements. At the end of the workout, a 10-minute cool-down session was performed, involving stretching exercises. The exercises included standing on the toes, lifting the side of the thigh, opening the knee, bending the knee behind the chair, standing stomach movement (folding the leg towards the stomach or hip flexion), lateral flexion of the spine, Incline Dumbbell Curl, hip extension behind the chair, squat in front of the chair, push up next to the wall, walking, front chest pull-up, or horizontal arm pull-up movement. Intervention 2: Control group: This group will not do any intervention.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
I will share the data with other researchers after completing the study with the participants while ensuring privacy.

When:
After printing and finishing the research, I will provide the data to the researchers.

To whom:
Researchers and people who use data for scientific advancement.

Conditions:
I will make it available to researchers to improve science. The data should be used anonymously and should not be misused.

Where to obtain:
Refer to the email of the responsible author.

How to obtain:
At first, it should be requested from the University of Tabriz and the supervisor, and then the responsible author will provide them to the researchers.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fatemeh Baharavar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 77, babaee 2, parvaz</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5167769811</zip>
        <telephone>+98 41 3386 2932</telephone>
        <email>baharavar.f@tabrizu.ac.ir</email>
        <affiliation>The university of Tabriz</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fatemeh Baharavar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No77, babae2, Parvaz square</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5167769811</zip>
        <telephone>+98 41 3386 2932</telephone>
        <email>baharavar.F@tabrizu.ac.ir</email>
        <affiliation>The university of Tabriz</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age range 60 to 70
Not taking medicine and supplements
Not having a specific disease
The doctor must approve the desired sports activity.</inclusion_criteria>
      <agemin>60 years</agemin>
      <agemax>70 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Having an underlying disease
Having skeletal disease</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: They will engage in circuit training 2 or 3 times a week (2 times initially and up to 3 times later) for eight weeks. Then, they will do stretching exercises for the major muscle groups and rotational movements. At the end of the workout, a 10-minute cool-down session was performed, involving stretching exercises. The exercises included standing on the toes, lifting the side of the thigh, opening the knee, bending the knee behind the chair, standing stomach movement (folding the leg towards the stomach or hip flexion), lateral flexion of the spine, Incline Dumbbell Curl, hip extension behind the chair, squat in front of the chair, push up next to the wall, walking, front chest pull-up, or horizontal arm pull-up movement.</i_keyword>
      <i_keyword>Control group: This group will not do any intervention.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Plasma nerve growth factor level in the elderly. Timepoint: Before and 48 hours after doing exercise. Method of measurement: Nerve growth factor concentration will be measured by blood sampling and by ELISA method and using kits with a sensitivity of 8.7 pg/ml, Promega brand, catalog number 7631G.</prim_outcome>
      <prim_outcome>Brain-derived neurotrophic factor will be assessed in the elderly population. Timepoint: before and 48 hours after doing the exercise. Method of measurement: The serum concentration of brain-derived neurotrophic factor will be measured by blood sampling and by ELISA using kits with a sensitivity of 15.6 pg/ml, Promega brand, catalog number 7611G.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Quality of life. Timepoint: It will be done two times, once before the protocol and once 48 hours after the completion of the protocol. Method of measurement: The World Health Organization's quality of life questionnaire will be used to measure the quality of life.</sec_outcome>
      <sec_outcome>People's physical fitness will be measured. Balance factors, cardiovascular endurance, muscle endurance, and body composition will be assessed to determine their effectiveness. Timepoint: It will occur twice, once before the protocol and once 48 hours later. Method of measurement: Functional tests for physical fitness: (stork tests to measure balance, 250-meter test to measure cardio-respiratory endurance, two minutes of walking to measure muscle endurance) and for body composition, the body mass index formula, which is weight divided by the square of height, will be used.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>The university of Tabriz</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-08-19</approval_date>
        <contact_name>ethic committee university of Tabriz</contact_name>
        <contact_address>No. 77, babaee2 Ave, Parvaz Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
